For example, in comparison with controls, CSF α-synuclein levels in AD were significantly higher, while PD, DLB and MSA subjects showed significantly lower levels of CSF α-synuclein than AD patients, but they did not significantly differ from CSF α-synuclein levels in the controls [38]. The gene discussed is SNCA; the disease is multiple system atrophy.